RegenMed Systems Inc.

RegenMed Systems Inc. manufactures the MarrowMiner, an FDA-cleared minimally invasive medical device for rapid bone marrow harvesting. The device represents the first significant advancement in bone marrow collection in over 50 years, enabling physicians to harvest bone marrow and marrow-derived stem cells from a single puncture under local anesthesia in 10-20 minutes—4-10 times faster than traditional aspiration methods. The MarrowMiner yields higher quantities of clinically-proven vital stem cell subtypes with greater consistency, supporting applications in bone marrow transplantation, orthopedic procedures, and regenerative medicine. The technology has been clinically validated and published in the Biology of Blood & Marrow Transplantation journal. By reducing procedure time, anesthesia requirements, and operating room utilization, the MarrowMiner simultaneously improves patient outcomes while reducing procedural costs, enabling broader adoption of stem cell-based therapies in both autologous and allogeneic marrow applications.